Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00882115 · ClinicalTrials.gov registry record · NA
Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00882115 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 38 participants.
The verdict
NCT00882115, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Allergic airway disease is a term used to describe conditions such as allergic rhinitis and asthma. Among other causative agents, air pollutants and diesel exhaust in particular, have been shown to create and also worsen existing allergic airway disease. These inhaled pollution particles have oxidative properties that drive inflammation-related effects through specific metabolic-associated processes. These processes are not adequately suppressed by current therapeutics. The purpose of this study is to explore the effects of broccoli sprout extract on the inflammatory process in the nose caused by diesel exhaust particles, which are important elements in air pollution. Broccoli sprout extract is a very potent inducer of Phase II enzymes (natural antioxidants).
Interventions
- DRUG Broccoli sprout extract (BSE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-07-10 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00882115
The ClinicalTrials.gov registry entry for NCT00882115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Broccoli sprout extract (BSE) is the first listed.
NCT00882115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00882115 about?
NCT00882115 is a clinical study titled "Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose". Allergic airway disease is a term used to describe conditions such as allergic rhinitis and asthma. Among other causative agents, air pollutants and diesel exhaust in particular, have been shown to create and also worsen existing allergic airway disease. These inhaled pollution particles have oxidat...
What is the current status of trial NCT00882115?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2009-07-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00882115?
The interventions under investigation include: Broccoli sprout extract (BSE) (DRUG).
Who is sponsoring clinical trial NCT00882115?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.